50% off Premium Yearly

NYSE:GMED
He recommended it around 18 months ago, and it has doubled in price. Drawbacks before: had no international presence and not enough salespeople, but that has turned around, as reflected in the price jump. Earnings growing 10-15% annually. No debt, but pay no dividend. Buy half a position and watch, but don't buy heavily because it may
drop badly during a correction.
Since he recommended this, it’s gone from $22 to $46. This is medical technology for spying related injuries. The stock price has taken off because the company has gotten their act together and has started to move outside of the US. Their sales teams are in place. A lot of their competitors have not been allocating capital towards the spine business. This company just came out with a new robotic invention that will help surgeons do all the spine surgeries. Earnings have jumped up nicely, and he is expecting anywhere from $143-$178 a share over the next couple of years, but we are still seeing the stock trading at roughly 32X earnings. Wait for a pullback or just buy half for the moment.
Globus Medical is a American stock, trading under the symbol GMED (previously GMED-N on Stockchase) on the New York Stock Exchange (GMED). It is usually referred to as NYSE:GMED or GMED
In the last year, no analyst issued a Buy, Sell, or Hold rating on GMED (previously GMED-N on Stockchase) on Stockchase. Read the latest expert commentary for Globus Medical.
Globus Medical was recommended as a Top Pick by David Driscoll on 2016-06-07. Read the latest stock experts ratings for Globus Medical.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Globus Medical.
Globus Medical is covered by Stockchase experts and is worth watching.
On 2026-06-18, Globus Medical (GMED) stock closed at a price of $79.21.